Xylan-oligosaccharides ameliorate high fat diet induced obesity and glucose intolerance and modulate plasma lipid profile and gut microbiota in mice
In recent years, xylan-oligosaccharides (XOS) have attracted much interest as an alternative sweetener for formulating an anti-obesity diet. The present study combining the plasma metabolic profile and gut microbiota analyses investigated the anti-obesity activity of XOS and the possible mechanism i...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-01-01
|
Series: | Journal of Functional Foods |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1756464619305468 |
id |
doaj-de23835e05df4833b7e15ca026243099 |
---|---|
record_format |
Article |
spelling |
doaj-de23835e05df4833b7e15ca0262430992021-04-30T07:17:37ZengElsevierJournal of Functional Foods1756-46462020-01-0164103622Xylan-oligosaccharides ameliorate high fat diet induced obesity and glucose intolerance and modulate plasma lipid profile and gut microbiota in miceChengnan Zhang0Abdullah Abdulaziz Abbod Abdo1Benariba Kaddour2Qiuhua Wu3Liang Xin4Xiuting Li5Guangsen Fan6Chao Teng7Beijing Advanced Innovation Center for Food Nutrition and Human Health, Beijing Technology and Business University, Beijing 100048, China; School of Food and Chemical Engineering, Beijing Technology and Business University, No. 11, Fucheng Road, Beijing 100048, ChinaBeijing Advanced Innovation Center for Food Nutrition and Human Health, Beijing Technology and Business University, Beijing 100048, China; School of Food and Chemical Engineering, Beijing Technology and Business University, No. 11, Fucheng Road, Beijing 100048, China; Department of Food Science and Technology, IBB University, IBB, YemenBeijing Advanced Innovation Center for Food Nutrition and Human Health, Beijing Technology and Business University, Beijing 100048, China; School of Food and Chemical Engineering, Beijing Technology and Business University, No. 11, Fucheng Road, Beijing 100048, ChinaBeijing Advanced Innovation Center for Food Nutrition and Human Health, Beijing Technology and Business University, Beijing 100048, China; School of Food and Chemical Engineering, Beijing Technology and Business University, No. 11, Fucheng Road, Beijing 100048, ChinaBeijing Advanced Innovation Center for Food Nutrition and Human Health, Beijing Technology and Business University, Beijing 100048, China; School of Food and Chemical Engineering, Beijing Technology and Business University, No. 11, Fucheng Road, Beijing 100048, ChinaBeijing Advanced Innovation Center for Food Nutrition and Human Health, Beijing Technology and Business University, Beijing 100048, China; Beijing Engineering and Technology Research Center of Food Additives, Beijing 100048, China; School of Food and Chemical Engineering, Beijing Technology and Business University, No. 11, Fucheng Road, Beijing 100048, China; Corresponding author at: Mailing address: Beijing Technology and Business University, No 11 Fucheng Street, Haidian District, Beijing 100048, China.Beijing Advanced Innovation Center for Food Nutrition and Human Health, Beijing Technology and Business University, Beijing 100048, China; School of Food and Chemical Engineering, Beijing Technology and Business University, No. 11, Fucheng Road, Beijing 100048, ChinaBeijing Advanced Innovation Center for Food Nutrition and Human Health, Beijing Technology and Business University, Beijing 100048, China; School of Food and Chemical Engineering, Beijing Technology and Business University, No. 11, Fucheng Road, Beijing 100048, ChinaIn recent years, xylan-oligosaccharides (XOS) have attracted much interest as an alternative sweetener for formulating an anti-obesity diet. The present study combining the plasma metabolic profile and gut microbiota analyses investigated the anti-obesity activity of XOS and the possible mechanism in mice. Our results showed that the dietary supplementations with 5% and 10% XOS could significantly slow down the body weight gaining and improve glucose intolerance. Lipidomic analyses revealed an alternation in 31 metabolic molecules, in particular the ceramide and diacylglycerol species, in the plasma, which were associated with the XOS supplement. Furthermore, gut microbiota analysis showed that XOS changed the composition of gut microbiota, leading to an increase in the relative population of genus Bifidobacterium, Lachnospiraceae_NK4A136_group and Roseburia. In conclusion, the XOS supplementation could reduce the progression of obesity, improve glucose intolerance, and change the plasma lipid profile and gut microbiota composition.http://www.sciencedirect.com/science/article/pii/S1756464619305468Xylan-oligosaccharidesObesityPlasma lipid profileGut microbiota |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Chengnan Zhang Abdullah Abdulaziz Abbod Abdo Benariba Kaddour Qiuhua Wu Liang Xin Xiuting Li Guangsen Fan Chao Teng |
spellingShingle |
Chengnan Zhang Abdullah Abdulaziz Abbod Abdo Benariba Kaddour Qiuhua Wu Liang Xin Xiuting Li Guangsen Fan Chao Teng Xylan-oligosaccharides ameliorate high fat diet induced obesity and glucose intolerance and modulate plasma lipid profile and gut microbiota in mice Journal of Functional Foods Xylan-oligosaccharides Obesity Plasma lipid profile Gut microbiota |
author_facet |
Chengnan Zhang Abdullah Abdulaziz Abbod Abdo Benariba Kaddour Qiuhua Wu Liang Xin Xiuting Li Guangsen Fan Chao Teng |
author_sort |
Chengnan Zhang |
title |
Xylan-oligosaccharides ameliorate high fat diet induced obesity and glucose intolerance and modulate plasma lipid profile and gut microbiota in mice |
title_short |
Xylan-oligosaccharides ameliorate high fat diet induced obesity and glucose intolerance and modulate plasma lipid profile and gut microbiota in mice |
title_full |
Xylan-oligosaccharides ameliorate high fat diet induced obesity and glucose intolerance and modulate plasma lipid profile and gut microbiota in mice |
title_fullStr |
Xylan-oligosaccharides ameliorate high fat diet induced obesity and glucose intolerance and modulate plasma lipid profile and gut microbiota in mice |
title_full_unstemmed |
Xylan-oligosaccharides ameliorate high fat diet induced obesity and glucose intolerance and modulate plasma lipid profile and gut microbiota in mice |
title_sort |
xylan-oligosaccharides ameliorate high fat diet induced obesity and glucose intolerance and modulate plasma lipid profile and gut microbiota in mice |
publisher |
Elsevier |
series |
Journal of Functional Foods |
issn |
1756-4646 |
publishDate |
2020-01-01 |
description |
In recent years, xylan-oligosaccharides (XOS) have attracted much interest as an alternative sweetener for formulating an anti-obesity diet. The present study combining the plasma metabolic profile and gut microbiota analyses investigated the anti-obesity activity of XOS and the possible mechanism in mice. Our results showed that the dietary supplementations with 5% and 10% XOS could significantly slow down the body weight gaining and improve glucose intolerance. Lipidomic analyses revealed an alternation in 31 metabolic molecules, in particular the ceramide and diacylglycerol species, in the plasma, which were associated with the XOS supplement. Furthermore, gut microbiota analysis showed that XOS changed the composition of gut microbiota, leading to an increase in the relative population of genus Bifidobacterium, Lachnospiraceae_NK4A136_group and Roseburia. In conclusion, the XOS supplementation could reduce the progression of obesity, improve glucose intolerance, and change the plasma lipid profile and gut microbiota composition. |
topic |
Xylan-oligosaccharides Obesity Plasma lipid profile Gut microbiota |
url |
http://www.sciencedirect.com/science/article/pii/S1756464619305468 |
work_keys_str_mv |
AT chengnanzhang xylanoligosaccharidesamelioratehighfatdietinducedobesityandglucoseintoleranceandmodulateplasmalipidprofileandgutmicrobiotainmice AT abdullahabdulazizabbodabdo xylanoligosaccharidesamelioratehighfatdietinducedobesityandglucoseintoleranceandmodulateplasmalipidprofileandgutmicrobiotainmice AT benaribakaddour xylanoligosaccharidesamelioratehighfatdietinducedobesityandglucoseintoleranceandmodulateplasmalipidprofileandgutmicrobiotainmice AT qiuhuawu xylanoligosaccharidesamelioratehighfatdietinducedobesityandglucoseintoleranceandmodulateplasmalipidprofileandgutmicrobiotainmice AT liangxin xylanoligosaccharidesamelioratehighfatdietinducedobesityandglucoseintoleranceandmodulateplasmalipidprofileandgutmicrobiotainmice AT xiutingli xylanoligosaccharidesamelioratehighfatdietinducedobesityandglucoseintoleranceandmodulateplasmalipidprofileandgutmicrobiotainmice AT guangsenfan xylanoligosaccharidesamelioratehighfatdietinducedobesityandglucoseintoleranceandmodulateplasmalipidprofileandgutmicrobiotainmice AT chaoteng xylanoligosaccharidesamelioratehighfatdietinducedobesityandglucoseintoleranceandmodulateplasmalipidprofileandgutmicrobiotainmice |
_version_ |
1721498968116953088 |